Vident Investment Advisory, LLC / VRTX
Vident Investment Advisory, LLC’s Vertex Pharmaceuticals Inc Position
Does Vident Investment Advisory, LLC own Vertex Pharmaceuticals Inc (VRTX)? Not currently — the last reported position was 53.1K shares worth $19M in Q2 2023; the fund’s latest 13F (Q3 2023) no longer reports it.
Position Value
$19M
Q2 2023
Shares
53.1K
% of Portfolio
+0.64%
Quarters Held
13
position exited
Position History VRTX
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q2 2023 | 53.1K | $19M | +0.64% |
| Q1 2023 | 57.6K | $18M | +0.59% |
| Q4 2022 | 53.3K | $15M | +0.58% |
| Q3 2022 | 32.0K | $9M | +0.29% |
| Q2 2022 | 36.3K | $10M | +0.31% |
| Q1 2022 | 41.5K | $11M | +0.28% |
| Q4 2021 | 30.1K | $7M | +0.17% |
| Q3 2021 | 20.5K | $4M | +0.11% |
| Q2 2021 | 3.1K | $616,000 | +0.02% |
| Q1 2021 | 3.8K | $808,000 | +0.03% |
| Q4 2020 | 2.2K | $521,000 | +0.02% |
| Q3 2020 | 2.0K | $553,000 | +0.03% |
| Q2 2020 | 3.2K | $935,000 | +0.05% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Vident Investment Advisory, LLC’s full portfolio or all institutional holders of VRTX.